News & Events

News related to Afinion can be found here together with information on congresses or exhibitions where the Afinion will feature.

Afinion Update

Dundee, Scotland, 8 January 2010: Axis-Shield plc (LSE:ASD, OSE:ASD), the international in-vitro diagnostics (IVD) company, today provides an update on the progress in 2009 of Afinion, its state-of-the-art, point-of-care analyser system, and announces a further acceleration of its commercialisation.

Afinion HbA1c Re-certified by NGSP

Afinion HbA1c has successfully completed the National Glycohemoglobin Standardization Program (NGSP, USA) manufacturer certification.

Axis-Shield Named Vendor of the Year by PSS in USA

Axis-Shield plc has been named “Vendor of the Year” by PSS (Physician Sales & Service), the largest distributor of medical supplies and services to office-based physicians in the United States.

Axis-Shield plc, Interim Results for the Six Months ended 30 June 2009

Axis-Shield plc announces its interim results for the six months ended 30 June 2009

Afinion Performance Affirmed In New Publication

Dundee, Scotland, 18 March 2009: Axis-Shield plc (LSE:ASD, OSE:ASD), the international in-vitro diagnostics (IVD) company, today announces that a new paper has been published confirming the performance of its Afinion Point-of-Care System and the assay for HbA1c, used to monitor efficacy of blood glucose control in diabetes.

Axis-Shield Afinion HbA1c Patent Granted In Japan

Axis-Shield have received notice of approval for its Japanese patent application governing the measuring methodology for HbA1c within the Afinion cassette for detection of this important marker of diabetic patient compliance.